What to do with an adult patient with leukocytosis (elevated white blood cell count) to 17,000 with neutrophilic predominance while on steroid (corticosteroid) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Steroid-Induced Leukocytosis: Management Approach

Do not stop the steroid based solely on a WBC of 17,000 with neutrophilic predominance, as this elevation is an expected physiologic response to corticosteroid therapy and does not indicate infection or harm. 1, 2

Understanding Steroid-Induced Leukocytosis

Expected Magnitude of WBC Elevation

  • High-dose steroids can increase WBC counts by up to 4.84 × 10⁹/L within 48 hours, with peak elevation occurring at this timeframe 1
  • Medium-dose steroids typically increase WBC by approximately 1.7 × 10⁹/L, while low-dose steroids cause increases of only 0.3 × 10⁹/L 1
  • Even small doses of prednisone administered over prolonged periods can induce extreme and persistent leukocytosis, with WBC counts exceeding 20,000/mm³ as early as the first day of treatment 2
  • In patients with acute infections on chronic steroid therapy, the average WBC increase is approximately 5 × 10⁹/L above baseline 3

Mechanism and Cell Distribution

  • Corticosteroids cause neutrophilic leukocytosis together with eosinopenia, monocytopenia, and lymphocytopenia through redistribution of cells from marginated pools into circulation 4
  • The leukocytosis is predominantly due to polymorphonuclear cells and coincides with monocytosis and eosinopenia 2
  • Neutrophil function remains intact despite steroid exposure, with preserved viability (98.4%), phagocytic capability (97.6%), and bactericidal activity (97.7%) 5

Distinguishing Steroid Effect from Infection

Key Diagnostic Features

The critical distinction is the presence or absence of a left shift and toxic granulation:

  • A left shift (≥16% band forms or absolute band count ≥1,500 cells/mm³) and toxic granulation are rare in pure steroid-induced leukocytosis but common in bacterial infection 2, 6
  • An absolute band count ≥1,500 cells/mm³ has a likelihood ratio of 14.5 for bacterial infection 6, 7
  • Neutrophil percentage >90% has a likelihood ratio of 7.5 for bacterial infection 7
  • Left shift ≥16% bands has a likelihood ratio of 4.7 for bacterial infection 7

Required Clinical Assessment

Order a peripheral blood smear with manual differential immediately to assess for:

  • Band forms and left shift 6
  • Toxic granulation 2
  • Blast cells or other malignant morphology 6

Evaluate for clinical signs of infection:

  • Fever, localized pain, or organ-specific symptoms 8
  • Blood cultures if systemic infection suspected 8, 6
  • Site-specific cultures based on clinical presentation 8
  • Imaging directed at suspected infection source 6

Clinical Decision Algorithm

If WBC 17,000 with neutrophilic predominance on steroids:

  1. Continue steroids if:

    • No left shift (<16% bands and absolute band count <1,500/mm³) 2
    • No toxic granulation 2
    • No fever or localizing signs of infection 8
    • Neutrophil percentage <90% 7
  2. Investigate for infection if:

    • Left shift present (≥16% bands or ≥1,500 absolute band count) 6, 2
    • Toxic granulation visible 2
    • Clinical signs of infection present 8
    • WBC increase exceeds expected steroid effect (>4.84 × 10⁹/L increase with high-dose steroids) 1
  3. Do not stop steroids unless:

    • Infection is confirmed and steroid continuation would compromise infection control 8
    • Patient requires immunosuppressive-dose steroids (>10 mg prednisone equivalent daily) and has uncontrolled active infection 9

Common Pitfalls to Avoid

  • Do not interpret steroid-induced leukocytosis as infection without assessing for left shift and toxic granulation 2
  • Do not stop necessary steroid therapy based solely on elevated WBC count, as this represents expected physiologic response 1, 2
  • Do not ignore leukocytosis in the absence of fever, particularly in older adults or immunocompromised patients, as infection can occur without fever 6
  • Do not overlook absolute neutrophil count elevation when total WBC is only mildly elevated, as left shift can indicate serious bacterial infection even with normal total WBC 6

References

Guideline

Initial Workup for Leukocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Neutrophilia Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Elevated White Blood Cell Count

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

In a patient receiving systemic steroids (e.g., prednisone ≥10–20 mg/day), how can I differentiate whether leukocytosis is due to infection or steroid effect?
How long do corticosteroids elevate White Blood Cell (WBC) count?
Can fludrocortisone cause leukocytosis (elevated peripheral white blood cell count) in patients treated for adrenal insufficiency?
In a patient who received a single 50 mg dose of prednisone and recently underwent chemotherapy, with a leukocyte count of 11.5 ×10⁹/L, elevated C‑reactive protein, and low‑grade fever (37.5‑37.7 °C), is the leukocytosis likely a prednisone side effect or indicative of an underlying inflammatory or infectious process?
Can steroids induce leukopenia?
What are the implications and management of an 8.8mm endometrial lining thickness in a postmenopausal woman?
What is the management for a patient with angioedema due to aceclofenac (Non-Steroidal Anti-Inflammatory Drug (NSAID)) treatment?
What are the guidelines for using oxymetazoline in adults and children over 6 years old with nasal congestion, considering potential interactions with hypertension, diabetes, and thyroid disease?
What is the recommended heparin dosing for a hemodialysis patient with deep vein thrombosis (DVT) or pulmonary embolism (PE) and impaired renal function?
Can small intestine bacterial overgrowth (SIBO) cause reflux, silent reflux, and associated symptoms like burping and throat irritation due to fermentation and pressure, and do acid reducers help alleviate these symptoms in a patient with a history of SIBO and negative Helicobacter pylori (H. pylori) test?
Can pelvic overexertion due to constipation or laxative use cause lasting nerve damage or tension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.